Inventor · disambiguated record
Cornelia Anne Mundt
Also filed as: MUNDT CORNELIA ANNE
21 granted patents·8 pending applications·59 citations·filing 2016–2025
94Inventor score
Top patents by PatentIndex Score
29 records- 0197US10912831B1Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Feb 9, 2021·6 cites·26 claims
- 0296US11638755B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted May 2, 2023·4 cites·20 claims
- 0394US11242385B2Anti-CD137 antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Feb 8, 2022·8 cites·24 claims
- 0494US10144779B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2016·Granted Dec 4, 2018·12 cites·92 claims
- 0593US11013802B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2017·Granted May 25, 2021·5 cites·21 claims
- 0692US11267889B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Mar 8, 2022·2 cites·26 claims
- 0792US10882908B2Anti-LAG-3 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Jan 5, 2021·2 cites·36 claims
- 0892US10479833B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2018·Granted Nov 19, 2019·8 cites·34 claims
- 0989US11345755B2Anti-PD-1 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted May 31, 2022·2 cites·25 claims
- 1089US10844119B2Anti-LAG-3 antibodies and methods of use thereofAGENUS INC·Filed 2017·Granted Nov 24, 2020·3 cites·32 claims
- 1188US2025206818A1Anti-lag-3 antibodies and methods of use thereofAGENUS INC·Filed 2024·Application pending·0 cites
- 1286US10323091B2Anti-PD-1 antibodies and methods of use thereofAGENUS INC·Filed 2016·Granted Jun 18, 2019·5 cites·94 claims
- 1385US12246066B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2023·Granted Mar 11, 2025·0 cites·19 claims
- 1484US11993653B2Antibodies and methods of use thereofAGENUS INC·Filed 2019·Granted May 28, 2024·2 cites·19 claims
- 1579US12492257B2Anti-CTLA-4 antibodies and methods of use thereofAGENUS INC·Filed 2022·Granted Dec 9, 2025·0 cites·20 claims
- 1678US12492393B2Anti-CD137 antibodies and methods of use thereofAGENUS INC·Filed 2021·Granted Dec 9, 2025·0 cites·28 claims
- 1776US2022372149A1Anti-pd-1 antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1875US12187795B2Anti-LAG-3 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Jan 7, 2025·0 cites·18 claims
- 1975US2025360209A1Anti-ctla-4 antibodies and methods of use thereofAGENUS INC·Filed 2025·Application pending·0 cites
- 2074US11993651B2Anti-lag-3 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted May 28, 2024·0 cites·15 claims
- 2174US11098117B2Anti-CD137 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Aug 24, 2021·0 cites·25 claims
- 2274US2022106581A1Anti-cd137 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 2366US10450373B2Anti-PD-1 antibodies and methods of use thereofAGENUS INC·Filed 2019·Granted Oct 22, 2019·0 cites·30 claims
- 2464US2024102044A1T cell receptors that bind to ny-eso-1 and methods of use thereofMINK THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2563US2024352122A1Anti-cd48 antibodies, antibody drug conjugates, and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2661US11613764B2T cell receptors that bind to NY-ESO-1 and methods of use thereofMINK THERAPEUTICS INC·Filed 2019·Granted Mar 28, 2023·0 cites·8 claims
- 2760US2025387504A1Antibody-drug conjugates of antineoplastic compounds and methods of use thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2855US11999786B2Anti-CD48 antibodies, antibody drug conjugates, and uses thereofNOVARTIS AG·Filed 2021·Granted Jun 4, 2024·0 cites·41 claims
- 2949US2024042051A1Mcl-1 inhibitor antibody-drug conjugates and methods of useROCCHETTI FRANCESCA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cornelia Anne Mundt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →